We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+21.28%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$3.14B
AUM Growth
+$411M
Cap. Flow
-$74.7M
Cap. Flow %
-2.38%
Top 10 Hldgs %
12.7%
Holding
454
New
42
Increased
88
Reduced
249
Closed
34

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$7.68M
2
OMC icon
Omnicom Group
OMC
+$4.45M
3
UNF icon
Unifirst Corp
UNF
+$3.85M
4
CHX
ChampionX
CHX
+$3.69M
5
AIR icon
AAR Corp
AIR
+$3.59M

Top Sells

Rank Stock Value
1
AJG icon
Arthur J. Gallagher & Co
AJG
+$8.83M
2
PWR icon
Quanta Services
PWR
+$6.43M
3
MSFT icon
Microsoft
MSFT
+$5.27M
4
FE icon
FirstEnergy
FE
+$4.39M
5
CCI icon
Crown Castle
CCI
+$4.19M

Sector Composition

Rank Sector Weight
1 Technology 17.88%
2 Financials 17.5%
3 Industrials 13.65%
4 Consumer Discretionary 13.14%
5 Healthcare 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAH icon
426
Cardinal Health
CAH
$55.4B
-9,755
Closed -$458K
CYTK icon
427
Cytokinetics
CYTK
$10.4B
-30,491
Closed -$660K
DOCU
428
DocuSign
DOCU
$11.5B
-2,508
Closed -$540K
FCN icon
429
FTI Consulting
FCN
$4.17B
-16,112
Closed -$1.71M
FE icon
430
FirstEnergy
FE
$27B
-153,044
Closed -$4.39M
HAE icon
431
Haemonetics
HAE
$3.92B
-10,181
Closed -$888K
HOUS
432
DELISTED
Anywhere Real Estate
HOUS
-93,378
Closed -$881K
IOVA icon
433
Iovance Biotherapeutics
IOVA
$2.96B
-32,633
Closed -$1.07M
NOC icon
434
Northrop Grumman
NOC
$82.2B
-6,936
Closed -$2.19M
NXRT
435
NexPoint Residential Trust
NXRT
$643M
-21,089
Closed -$935K
PD icon
436
PagerDuty
PD
$917M
-36,184
Closed -$981K
PLMR icon
437
Palomar
PLMR
$3.41B
-10,357
Closed -$1.08M
PZZA icon
438
Papa John's
PZZA
$775M
-30,896
Closed -$2.54M
RLMD icon
439
Relmada Therapeutics
RLMD
$503M
-7,328
Closed -$276K
SAM icon
440
Boston Beer
SAM
$1.88B
-1,379
Closed -$1.22M
TTWO icon
441
Take-Two Interactive
TTWO
$47.4B
-18,200
Closed -$3.01M
XRAY icon
442
Dentsply Sirona
XRAY
$2.36B
-6,108
Closed -$267K
EVBG
443
DELISTED
Everbridge, Inc. Common Stock
EVBG
-9,051
Closed -$1.14M
CVET
444
DELISTED
Covetrus, Inc. Common Stock
CVET
-37,125
Closed -$906K
MANT
445
DELISTED
Mantech International Corp
MANT
-10,276
Closed -$708K
ZNGA
446
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-196,619
Closed -$1.79M
XLNX
447
DELISTED
Xilinx Inc
XLNX
-3,959
Closed -$413K
BMCH
448
DELISTED
BMC Stock Holdings, Inc
BMCH
-28,523
Closed -$1.22M
MYOK
449
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-12,120
Closed -$1.65M
UN
450
DELISTED
Unilever NV New York Registry Shares
UN
-4,910
Closed -$297K

Similar funds

Chartwell Investment Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Chartwell Investment Partners held 454 positions worth $3.14B, up 15% from $2.73B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Chartwell Investment Partners's Q4 2020 filing shows 42 new, 88 increased, 249 reduced and 34 closed positions. Its largest new stake was Ciena: 172,929 shares worth $9.14M. The largest sale was Arthur J. Gallagher & Co, an estimated $8.83M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.

  • Chartwell Investment Partners's largest Q4 2020 buy was Ciena: 172,929 shares worth $9.14M.
  • Chartwell Investment Partners added most to Unifirst Corp in Q4 2020, an estimated $3.85M increase.
  • Chartwell Investment Partners's biggest Q4 2020 reduction was Arthur J. Gallagher & Co, cutting an estimated $8.83M.
  • Chartwell Investment Partners fully exited FirstEnergy in Q4 2020, selling an estimated $4.39M.
  • Chartwell Investment Partners's ten largest holdings make up 13% of its $3.14B portfolio in Q4 2020.
  • Chartwell Investment Partners opened 42 new positions and closed 34 in Q4 2020.
  • Chartwell Investment Partners's portfolio value rose 15% quarter-over-quarter to $3.14B.

Based on Chartwell Investment Partners's 13F filing for Q4 2020, filed 9 Feb 2021.